Email This Article

Headlines & Perspectives
Provenge Doc: FDA Has All the Data It Needs
By Adam Feuerstein
04/28/09 - 06:26 PM EDT
Dendreon's latest Provenge data answer all the questions the FDA raised two years ago, says an investigator in the trial.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,388.90 1,105.98 2,194.35 34.83
Oil *
77.74
UP
22.75
UP
6.06
UP
21.21
UP
1.03
10 Yr
3.48%
SPDR Gold
113.75
+0.22%
+0.55%
+0.98%
+3.05%
Data delayed 20 minutes

Brokerage Partners